Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER Meeting Abstract
| Authors: | Strickler, J. H.; Cercek, A.; Ng, K.; Siena, S.; AndreĢ, T.; Van Cutsem, E.; Wu, C.; Paulson, A. S.; Hubbard, J.; Coveler, A. L.; Fountzilas, C.; Kardosh, A.; Kasi, P. M.; Lenz, H. J.; Ciombor, K. K.; Fernandez, M. E. E.; Stecher, M.; Cronin, P.; Bieda, M.; Bekaii-Saab, T. |
| Abstract Title: | Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER |
| Meeting Title: | Annals of Oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-01-01 |
| Start Page: | S411 |
| End Page: | S412 |
| Language: | English |
| ACCESSION: | WOS:001087480200538 |
| DOI: | 10.1016/j.annonc.2023.09.1742 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 551O -- Source: Wos |
